(*) USA Approval Date: 2021. 02.05>
(*) USA Approval Date: 2022. 06.24
Company
DLBCL: diffuse large B-cell lymphom
Generic N: Lisocabtagene Maraleucel
LBCL: large B-cell lymphoma
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 02.09.
RTM
RTM Web-Site